Results 221 to 230 of about 45,700 (265)

Finerenone in patients with severe heart failure: The FINEARTS‐HF trial

open access: yesEuropean Journal of Heart Failure, EarlyView.
Severe heart failure and treatment with finerenone. CI, confidence interval; CV, cardiovascular; HF, heart failure; LVEF, left ventricular ejection fraction; RR, rate ratio. Aims While patients with severe heart failure (HF) were historically considered to have reduced left ventricular ejection fraction (LVEF), it is increasingly recognized that severe
Riccardo M. Inciardi   +24 more
wiley   +1 more source

The addition of vericiguat to sacubitril/valsartan improved the composite endpoint. Add a finishing touch on heart failure medical therapy by vericiguat as secret ingredient

open access: yes
European Journal of Heart Failure, EarlyView.
Haruyuki Kinoshita   +13 more
wiley   +1 more source

Adherence to guideline‐directed medical treatments in heart failure. A scientific statement of the Heart Failure Association (HFA) of the ESC and the ESC Working Group on Cardiovascular Pharmacotherapy

open access: yesEuropean Journal of Heart Failure, EarlyView.
Heart failure (HF) affects over 60 million individuals globally. Contemporary guideline‐directed medical therapies (GDMT) reduce cardiovascular mortality and HF hospitalizations. However, medication non‐adherence represents a critical barrier limiting real‐world efficacy of GDMT.
Gianluigi Savarese   +37 more
wiley   +1 more source

Aldosterone in Chronic Kidney Disease. [PDF]

open access: yesBiomedicines
Polenus P   +2 more
europepmc   +1 more source

Sodium–glucose co‐transporter 2 inhibitors in severe estimated glomerular filtration rate deterioration across cardiovascular‐kidney‐ metabolic conditions: A pooled analysis of randomized trials

open access: yesEuropean Journal of Heart Failure, EarlyView.
Aims The efficacy of sodium–glucose co‐transporter 2 inhibitors (SGLT2i) among patients with cardiovascular‐kidney‐metabolic (CKM) conditions who experience severe estimated glomerular filtration rate (eGFR) deterioration during follow‐up is not well established.
João Pedro Ferreira   +10 more
wiley   +1 more source

Short-term longitudinal clinical, biochemical, and quality of life outcomes of medical or surgical therapy in unilateral primary aldosteronism. [PDF]

open access: yesFront Endocrinol (Lausanne)
Yoshida Y   +14 more
europepmc   +1 more source

Prenatal betamethasone–postnatal N‐methyl‐D‐aspartic acid model of spasms: Update on mechanisms and treatments

open access: yesEpilepsia Open, EarlyView.
Abstract Infantile epilepsy spasms syndrome (IESS), formerly known as infantile spasms or West Syndrome, is a severe epilepsy syndrome affecting about 3 in 10,000 newborns in the United States. Characterized by clusters of epileptic spasms, interictal hypsarrhythmia, and developmental delays, IESS has diverse causes, including structural‐metabolic ...
Kayla Vieira   +5 more
wiley   +1 more source

Nurse Specialising Consultation in Heart Failure: Impact on Drug Titration and Cardiovascular Events in Patients with Heart Failure and Reduced Ejection Fraction. [PDF]

open access: yesJ Clin Med
Lopez-Aguilera J   +15 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy